Basics Phathom Pharmaceuticals, Inc. IPO Date: October 21, 2019 Sector: Healthcare Industry: Biotech Market Cap: $1.04B Activated in VL: True Average Daily Range Avg Daily Range: $0.63 | 3.58% Avg Daily Range (30 D): $0.30 | 2.12% Avg Daily Range (90 D): $0.32 | 2.64% Institutional Daily Volume Avg Daily Volume: .45M Avg Daily Volume (30 D): .78M Avg Daily Volume (90 D): .91M Trade Size Avg Trade Size (Sh.): 90 Avg Trade Size (Sh.) (30 D): 76 Avg Trade Size (Sh.) (90 D): 80 Institutional Trades Total Inst.Trades: 826 Avg Inst. Trade: $1.48M Avg Inst. Trade (30 D): $1.17M Avg Inst. Trade (90 D): $1.42M Avg Inst. Trade Volume: .11M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.4M Avg Closing Trade (30 D): $1.28M Avg Closing Trade (90 D): $1.15M Avg Closing Volume: 102.37K     News Oct 23, 2025 @ 12:00 PM Phathom Pharmaceuticals to Highlight VOQUEZNA® ... Source: Phathom Pharmaceuticals Oct 20, 2025 @ 12:00 PM Phathom Pharmaceuticals to Report Third Quarter 20... Source: Phathom Pharmaceuticals Aug 20, 2025 @ 12:00 PM Phathom Pharmaceuticals Clarifies That There Is No... Source: Nick Benedetto Jul 28, 2025 @ 12:00 PM Phathom Pharmaceuticals to Report Second Quarter 2... Source: Phathom Pharmaceuticals Apr 16, 2025 @ 12:00 PM Phathom Pharmaceuticals Appoints Ted Schroeder to ... Source: N/A Financials   TTM Q3 2025 Q2 2025 Basic EPS $-3.77 $-.41 $-1.05 Diluted EPS $-3.77 $-.41 $-1.05 Revenue $ 147.19M $ 49.5M $ 39.5M Gross Profit $ 128.42M $ 43.31M $ 34.47M Net Income / Loss $ -274.55M $ -29.97M $ -75.81M Operating Income / Loss $ -213.47M $ -15.27M $ -59.92M Cost of Revenue $ 18.77M $ 6.19M $ 5.04M Net Cash Flow $ -199.52M $ -14.41M $ -147.69M PE Ratio